Page 125 - MBCA_FULL REPORT_FINAL_FOR_WEB
P. 125

Basic research awards         Translational research awards          Clinical research awards
         lysine oxidase (LOX)   0.4%   tumor associated macrophages   0.4%    receptor tyrosine kinase        0%
                                       (TAMs)
         PAR                    0.4%   TWIST transcription factos    0.4%     EGF pathway                     0%
         SLUG/SNAIL             0.3%   PGE2 receptors                0.3%     nuclear protooncoproteins       0%
         Actin                  0.3%   HLA                           0.3%     FAK                             0%
         Abl Kinases            0.3%   S100 family of Ca2+-binding pro-  0.3%  tumor suppressor genes         0%
                                       teins
 Basic research awards  Translational research awards  Clinical research awards  p53 pathway  0.3%  TF Signaling  0.3%  Interleukins  0%
 Pathway (Group)  Total  Molecular Target (Group)  Total  Molecular Target (Group)  Total
 Other  22.0%  Other  23.4%  Other  24%  BRCA  0.3%  Src + family    0.3%     HOX family transcription factors  0%
                                                                              metastasis suppressor genes
                                                                     0.3%
         HDAC
                                0.3%
                                                                                                              0%
                                       transcription factor
 Multiple  12.5%  0_No specific target  16.4%  0_No specific target  17%
 Bone/osteolysis pathways  6.7%  Multiple  7.4%  Multiple  11%  HOX homeobox factors  0.3%  p53 pathway  0.3%  immunophilin proteins  0%
                                                                              PTHrP
                                                                     0.3%
                                       immunophilin proteins
                                0.3%
                                                                                                              0%
         AKT
 Pathway not specified  4.9%  Integrins, Cadherins etc.  3.9%  Erb/Her  6%
 Angiogenic pathways  4.6%  Erb/Her  3.1%  hormone receptors  5%  Phosphoinsitide signaling  0.3%  anthrax toxin receptor 2 (CMG2)  0.3%  telomeres  0%
                                                                     0.3%
         COX
                                0.3%
                                       Plasminogen signalling
                                                                                                              0%
                                                                              SDF-1
 Integrins, Cadherins etc.  3.4%  cytokines and chemokines  3.0%  VEGF pathway family  3%
 TGF  3.3%  Bone/osteolysis pathways  2.7%  (blank)  3%  Fibroblast activation pro-  0.3%  Retinoids  0.3%  G-protein coupled receptors  0%
         tein (FAP)
 cytokines and chemokines  2.9%  Stem cells  2.5%  IGF signalling  3%  SDF-1  0.3%  telomeres  0.3%  Ezrin    0%
 Stem cells  1.8%  TGF  2.1%  Bone/osteolysis pathways  3%  adhesion molecules  0.2%  PI3 kinase  0.2%  HDAC  0%
 Hypoxia factors  1.5%  matrix metalloproteinases  2.0%  HGF/MET  2%  IBC  0.2%  Vitamin D pathway  0.2%  tumor associated macrophages   0%
 matrix metalloproteinases  1.5%  VEGF pathway family  1.8%  urokinase (uPA-R) pathway  2%  (TAMs)
 Rho family GTPases  1.4%  (blank)  1.8%  angiogenesis factor  2%  sympathetic nervous sys-  0.2%  Hedgehog  0.2%  SIX family genes  0%
 VEGF pathway family  1.4%  angiogenesis factor  1.7%  Immune system (general)  2%  tem (SNS) signalling
 Erb/Her  1.4%  Circulating tumour cells (CTC)  1.4%  thymidylate synthase  2%  tumor necrosis family (TNF)  0.2%  bcl-2 family  0.2%  Hypoxia factors  0%
 Immune system (general)  1.3%  Hypoxia factors  1.4%  p53 pathway  2%  superfamily
 Src + family  1.0%  NF Kappa B pathway  1.2%  Integrins, Cadherins etc.  1%  Oncostatin M  0.2%  tumor homing peptides  0.2%  G protein coupled receptors  0%
 NF Kappa B pathway  1.0%  hormone receptors  1.0%  Src + family  1%  PTEN  0.2%  src kinase substrate  0.2%  Vitamin D pathway  0%
 hormone receptors  1.0%  Interleukins  0.9%  cytokines and chemokines  1%  p21 activated kinase (PAK)  0.2%  Ras pathway  0.2%  lysophospholipid family  0%
 microRNAs (miRNAs)  1.0%  urokinase (uPA-R) pathway  0.9%  COX  1%  Crk family  0.2%  autocrine motility factor (AMF)  0.2%  Cell surface glycoproteins  0%
 Six family genes  0.8%  Immune system (general)  0.9%  Stem cells  1%  telomeres  0.2%  STAT  0.2%  scaffolding adapters  0%
         tumor microenvironment  0.2%  endoglycosidases              0.2%     HLA                             0%
 FAK  0.8%  EGF pathway  0.8%  HSP  1%
 Twist  0.8%  cysteine proteases  0.8%  TGF  1%  p38 pathways  0.2%  Notch pathway  0.2%  claudins            0%
         brain                  0.2%   disintegrin family            0.2%     tumor homing peptides           0%
 STAT  0.7%  tumor necrosis family (TNF)    0.8%  Ras pathway  1%
 superfamily  TF Signaling      0.2%   SDF-1                         0.2%     Plasminogen signalling          0%
 receptor tyrosine kinase  0.6%  Fibroblast activation protein (FAP)  0.7%  PI3 kinase  1%  ezrin  0.2%  sialylation  0.2%  Retinoids  0%
 Cell surface glycoproteins  0.6%  IGF signalling  0.7%  disintegrin family  1%  map kinases  0.2%  tubulin binding agent  0.2%  autocrine motility factor (AMF)  0%
 cytoskeleton  0.6%  COX  0.7%  breast tumor suppressors  1%  transcription factor  0.2%  metastasis suppressor genes  0.2%  Cystatin M  0%
 Protein kinases  0.5%  Ephrins  0.7%  Circulating tumour cells (CTC)  1%  Interleukins  0.2%  receptor tyrosine kinase  0.2%  Ubiquitin ligases  0%
 Ras pathway  0.5%  HSP  0.6%  MUC1  0%  ALDH  0.2%  HDAC            0.2%     NF Kappa B pathway              0%
 HGF/MET  0.5%  NK cells  0.6%  matrix metalloproteinases  0%  serine protease  0.2%  Thrombospondins  0.2%  SLUG/SNAIL  0%
 Collagen  0.5%  p38 pathway  0.5%  minor fatty acids  0%  IGF signalling  0.2%  G-protein coupled receptors  0.2%  STAT  0%
 MUC1  0.5%  Galectins  0.5%  ID-2/ID-1  0%  Plasminogen signalling  0.2%  miRNAs  0.2%  p21-activated kinase (Pak1)  0%
 stress pathways  0.5%  Rho family GTPases  0.5%  tumor necrosis family (TNF) super-  0%  HSP  0.2%  protein tyrosine kinase  0.2%  TF Signaling  0%
 family  Leptin                 0.2%   lysine oxidase (LOX)          0.1%     BCRP                            0%
 FGF signalling  0.5%  Cell surface glycoproteins  0.5%  Rho family GTPases  0%  Hedgehog  0.2%  indoles  0.1%  metastasis associated (MTA)  0%
 brain metastases  0.5%  ID-2/ID-1  0.4%  FGF signalling  0%  Notch pathway  0.2%  breast tumor suppressors  0.1%  NK cells  0%
 Ephrins  0.4%  MUC1  0.4%  Fibroblast activation protein (FAP)  0%  liver  0.2%  Protein-tyrosine kinases (PTKs)   0.1%  miRNAs  0%
 Wnt signalling  0.4%  AKT PKB signalling  0.4%  prolactin (PRL)   0%  SATB1  0.2%  Sphingosines  0.1%  anthrax toxin receptor 2 (CMG2)  0%
 insulin receptor substrate   0.4%  FAK  0.4%  transcription factor  0%  Neuropilin  0.2%  metastasis associated (MTA)  0.1%  sialylation  0%
 (IRS)   ADAM                   0.2%   lysophospholipid family       0.1%     endoglycosidases                0%
 metastasis suppressor   0.4%  PTHrP  0.4%  proteases  0%  tumor suppressor genes  0.2%  proteases  0.1%  Galectins  0%
 genes
   120   121   122   123   124   125   126   127   128   129   130